AKT1 and lung carcinoma: To further confirm the inhibitory effect of NSC609077 on the expression of the EGFR/PI3K/AKT axis, H1975 and A549 lung cancer cells were treated with the respective IC20 dose of NSC609077 for 48 h; Western blot analysis was then performed.